Youthink has stopped manufacturing for a shorter period where we're doing remediation. We expect to be back manufacturing here at the end of the quarter. In terms of us thinking about sandas, we are not really looking into it. It's not something we wold be interested in. That was cor sholtz, president in ceo of generic drug maker teva, still ahead on blimburg business.
Featuring some of our favorite conversations of the week from our daily radio show "Bloomberg Businessweek."
Hosted by Carol Massar and Tim Stenovec
Hear the show live at 2PM ET on WBBR 1130 AM New York, Bloomberg 106.1 FM Boston, Bloomberg 960 AM San Francisco, WDCH 99.1 FM in Washington D.C. Metro, Sirius/XM channel 119, on the Bloomberg Business App, Radio.com, the iHeartRadio app and at Bloomberg.com/audio.
You can also watch Bloomberg Businessweek on YouTube - just search for Bloomberg Global News.
Like us at Bloomberg Radio on Facebook and follow us on Twitter @carolmassar @timsteno and @BW
See omnystudio.com/listener for privacy information.